Unlike general health products stocked in every health store, CJC-1295 reaches researchers through a dedicated online market that Heyou residents reach through online vendors. The practical advantage of this online-only market is that serious vendors are judged entirely by their analytical documentation, giving researchers access to better quality signals than any local market ever offers. Separating properly characterised CJC-1295 from the rest of the market depends on three things: an HPLC chromatogram confirming ≥98% purity, mass spec data verifying the correct molecular weight, and a batch-specific endotoxin panel. The sections below cover what Heyou researchers need to know about finding, evaluating, and storing CJC-1295 for scientific research use.
CJC-1295 Mechanisms Explained
CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analogue with an extended half-life achieved through DAC technology that enables covalent binding to albumin. This modification extends the half-life from minutes (for native GHRH) to approximately 6-8 days, creating a sustained elevation in basal GH levels rather than the pulsatile pattern produced by GHRP compounds. This pharmacokinetic distinction is significant for research design: CJC-1295 based on CJC-1295 with DAC produces a different GH secretion pattern than GHRP compounds, with different downstream effects on IGF-1 and protein synthesis. Researchers in Heyou comparing compounds in this class should account for these pharmacokinetic differences in their experimental design.
Buying CJC-1295: Quality Markers to Look For
Vetting CJC-1295 vendors requires starting from the COA: locate the batch-specific certificate before placing an order, not after. Mass spectrometry in the COA confirms that the main HPLC peak is actually CJC-1295 and not a structurally similar impurity — HPLC purity alone provides no identity confirmation. Strong quality indicators beyond COA quality: documented vendor history spanning multiple years, customer service that can discuss analytical methods, and shipping with desiccant and appropriate cold protection. Bacteriostatic water is the correct reconstitution medium for CJC-1295 — it contains 0.9% benzyl alcohol that prevents microbial contamination and extends reconstituted shelf life to 4 weeks when kept refrigerated.
Order CJC-1295 — ships to Heyou
COA-verified · International tracking · Research grade
All use of CJC-1295 in Heyou or anywhere is research use only — this compound is not approved for therapeutic human application, and all handling should comply with standard research safety practices. Reconstitute CJC-1295 with bacteriostatic water at the concentration suited to your research design; a standard 5mg in 2mL gives a 2.5mg/mL solution — or 25mcg per insulin syringe unit. The primary quality-related safety risk in CJC-1295 research is endotoxin contamination from poor sourcing — a verified endotoxin panel in the batch COA is the key safeguard. Researchers running multi-compound protocols with CJC-1295 should review the available literature for documented interactions before proceeding with any multi-compound protocol.
Frequently Asked Questions
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
